Monograph
C01CA14 - Dopexamine |
Propably not porphyrinogenic |
PNP |
Rationale
Catecholamine. Non-CYP metabolism. No data pointing to CYP-interaction.
Chemical description
Catecholamine.
Therapeutic characteristics
Synthetic catecholamine used in intravenous short-duration treatment of chronic heart failure. Administered in infusion 1-6 ug/kg/minute in 0.9 %NaCl or 5% glucose solution.
Metabolism and pharmacokinetics
Metabolized in the liver via O-methylation and O-sulfatation of the catechol hydroxyl group. Half time in blood 6-7 minutes.
Similar drugs
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Dopacard
© NAPOS 2025